Showing results (11-20 of 92) with videos related to
Sort By:
Pageof 10
Movement Disorders : Official Journal of the Movement Disorder Society|January 4, 2018
Selected health and lifestyle factors, cytosine-adenine-guanine status, and phenoconversion in Huntington's diseaseCaroline Tanner, Karen Marder, Shirley Eberly, et al.Movement Disorders : Official Journal of the Movement Disorder Society|September 5, 2002
Test-retest reliability of the unified Parkinson's disease rating scale in patients with early Parkinson's disease: results from a multicenter clinical trialAndrew Siderowf, Michael McDermott, Karl Kieburtz, et al.Journal of Huntington'S Disease|November 8, 2018
Disease Progression in Huntington Disease: An Analysis of Multiple Longitudinal OutcomesTanya P Garcia, Yuanjia Wang, Ira Shoulson, et al.Journal of Parkinson'S Disease|July 27, 2014
Impact of disclosure of individual imaging results in a multi-center Parkinson clinical trialDanna Jennings, Shirley Eberly, David Oakes, et al.Communication & Medicine|November 25, 2015
Data sharing for public health research: A qualitative study of industry and academiaPamela A Saunders, Erin E Wilhelm, Sinae Lee, et al.Journal of Diabetes and Its Complications|September 24, 2017
A comprehensive review of the FDA-approved labels of diabetes drugs: Indications, safety, and emerging cardiovascular safety dataEvgenia Gourgari, Erin E Wilhelm, Hamid Hassanzadeh, et al.Journal of Parkinson'S Disease|July 12, 2021
Predictive Value of Verbatim Parkinson's Disease Patient-Reported Symptoms of Postural Instability and FallingMonica Javidnia, Lakshmi Arbatti, Abhishek Hosamath, et al.Journal of Clinical Lipidology|August 31, 2010
Altered cholesterol and fatty acid metabolism in Huntington diseaseRobert C Block, E Ray Dorsey, Christopher A Beck, et al.Journal of Huntington'S Disease|October 8, 2015
Informativeness of Early Huntington Disease Signs about Gene StatusEmily Oster, Shirley W Eberly, E Ray Dorsey, et al.Journal of Pharmacokinetics and Pharmacodynamics|April 21, 2006
Disease progression and pharmacodynamics in Parkinson disease - evidence for functional protection with levodopa and other treatmentsNicholas H G Holford, Phylinda L S Chan, John G Nutt, et al.Pageof 10